Upstox Promo
Upstox Promo
IPO Analysis > chemkart-india-bse-sme

 

Chemkart India IPO Highlights Investors Should Know

The global nutraceutical market is valued at nearly USD 400 billion, bringing together the worlds of food, medicine, and science. It’s one of the fastest-growing industries today. Chemkart India, with its presence in the nutraceutical space, has been part of this journey. The company is taking a big step forward and going public. This move marks an exciting new chapter for Chemkart as it aims to grow.

The Chemkart India IPO lead manager is Smart Horizon Capital Advisors, while the registrar of this IPO is Bigshare Services Limited.  

Check the RHP for more Chemkart India IPO Details.

Note: For 50% of the shares, the anchor lock-in period expires 30 days following the actual allocation, and for the remaining part, it ends 90 days later.

Chemkart India IPO Details: Company Profile

Let’s take a look at the important information related to the Chemkart India IPO


Particulars

Details

Established 

2020

Registered Office 

Mumbai, Maharashtra

Promoter

Ankit Shailesh Mehta

Products 

Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, Vitamin and many more

Warehousing Facility 

Spreads across 28,259.16 Sq Ft.

Competitors

No Competitors in India 


Exploring the Chemkart India IPO Details

Check everything about the company before you go for the Chemkart India IPO subscription.

  • Chemkart India IPO Date

Take a look at the official IPO calendar to get a better Chemkart India IPO review.


Event Description

Date

Start of public issue

07 Jul 2025

Last date to submit IPO applications

09 Jul 2025

Deadline for UPI authorisation (payment confirmation)

09 Jul 2025 (5 PM)

Basis of allotment finalised

10 Jul 2025

Refunds begin for unallotted applicants

11 Jul 2025

Equity shares credited to demat accounts

11 Jul 2025

Expected listing on the stock exchange

12 Jul 2025

Expiry of the UPI mandate validity period

24 Jul 2025

50% lock-in ends for anchor investors

09 Aug 2025

Full lock-in period ends for anchor investors

08 Oct 2025


  • Chemkart India IPO lot size

Discover Chemkart IPO lot size here.


Particulars

Number of Equity Shares

Aggregate Value

Fresh Issue 

26,00,000

₹64.48 crores

Offer for Sale

6,29,200 

₹15.60 crores

Overall Issue 

32,29,200

₹80.18 crores


  • Objectives of the offer 

Understand the allocation strategy of Chemkart India.


Use of Proceeds

Amount (₹ lakhs)

Investment in a wholly-owned subsidiary (Easy Raw Materials Private Limited) for setting up a manufacturing unit

3,468.33

Payment or partial settlement of existing borrowings taken by the company

2,000.00

Allocation for general business purposes

Not Disclosed


  • Other takeaways from the Chemkart India IPO Price

Let’s walk through the important Chemkart India IPO share price details.


Particulars

Description

Face value of each share

₹10

Price Range

₹236 - ₹248

Listed At 

BSE SME


  • Categorisation of different investors

The bid limits for retail investors, HNIs, and QIBs have been clearly outlined here.


Particulars

Market Maker

QIBs

Non-Institutional Investors

Retail Individual Investors

Number of Equity Shares

1,66,200

Not more than 15,21,000 shares

Not less than 4,63,200 shares

Not less than 10,78,800 shares

Minimum Bid Size

Not Disclosed

In multiples as per investment norms

Above ₹2,00,000

More than two lots

Maximum Bid Size

Not Disclosed

Up to full offer size (excluding anchor)

As per legal limits and offer size

Subject to legal cap and lot multiples


Open your Demat account today to apply for the Chemkart India IPO and start your investment journey without missing out!

Chemkart India IPO details: Key Financials 


The numbers below reveal if margins and revenue are moving in the right direction.


Particulars

2025 (₹ lakhs)

2024 (₹ lakhs)

2023 (₹ lakhs)

Equity Share Capital

949.90

135.70

135.70

Net Worth

5,328.57

2,901.47

1,449.65

Total Income

20,545.63

13,282.77

13,168.62

Restated Profit/(Loss) After Tax

2,425.75

1,451.82

766.02

Earnings Per Share (Basic & Diluted)

25.54

15.28

8.06

Net Asset Value Per Equity Share

56.10

30.55

15.26

Total Borrowings

1,702.82

1,254.75

1,133.22


Metrics of Chemkart India IPO 


Key Financial Performance

March 31, 2025

March 31, 2024

March 31, 2023

EBITDA Margin

16.12%

15.84%

8.41%

Net Profit Ratio

0.12

0.11

0.06

Return on Equity

0.59

0.67

0.72

Return on Capital Employed

0.49

0.51

0.43

Debt-Equity Ratio

0.32

0.43

0.78

Net Fixed Asset Turnover Ratio

23.40

24.81

23.68

Current Ratio

2.36

1.99

1.41


Strengths and risks

Here’s a balanced review that brings out the full picture of the Chemkart India IPO for better decision-making.


Strengths


  • Located close to Mumbai port, so goods move quickly from the ship to storage.

  • Quick to spot trends, which helps launch new products faster than others.

  • Good ties with B2B clients bring repeat orders and steady relationships.

  • Covers many health product types, so it attracts a wide range of customers.


Risks


  • Negative cash flow in recent times might limit business growth.

  • Too much dependence on a few suppliers, and there are no binding deals in place.

  • Losing rented office space might affect daily work and bring extra costs.

  • Not much background in the health supplement field may affect quality checks or future plans.

IPO Closing Soon: Is Chemkart India IPO Worth the Rush?

At this point, the Chemkart India IPO GMP hasn’t been active. But be sure to check the Chemkart India share price and important deadlines so you don’t miss any steps before allotment.


Get started with your Chemkart India IPO allotment process today.